{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T05:06:47Z","timestamp":1664255207512},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00108-022-01388-8","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T14:02:59Z","timestamp":1660572179000},"page":"1051-1058","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Klonale H\u00e4matopoese\u00a0\u2013 Ursachen und klinische Implikationen"],"prefix":"10.1007","volume":"63","author":[{"given":"Andreas","family":"Burchert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"issue":"12","key":"1388_CR1","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1182\/bloodadvances.2019000039","volume":"3","author":"S Scala","year":"2019","unstructured":"Scala\u00a0S, Aiuti\u00a0A (2019) In vivo dynamics of human hematopoietic stem cells: novel concepts and future directions. Blood Adv 3(12):1916\u20131924","journal-title":"Blood Adv"},{"issue":"11","key":"1388_CR2","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/ng.2413","volume":"44","author":"L Busque","year":"2012","unstructured":"Busque\u00a0L, Patel\u00a0JP, Figueroa\u00a0ME et\u00a0al (2012) Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat Genet 44(11):1179\u20131181","journal-title":"Nat Genet"},{"issue":"5","key":"1388_CR3","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1101\/gr.162131.113","volume":"24","author":"H Holstege","year":"2014","unstructured":"Holstege\u00a0H, Pfeiffer\u00a0W, Sie\u00a0D et al (2014) Somatic mutations found in the healthy blood compartment of a\u00a0115-yr-old woman demonstrate oligoclonal hematopoiesis. Genome Res 24(5):733\u2013742","journal-title":"Genome Res."},{"issue":"26","key":"1388_CR4","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese\u00a0G, K\u00e4hler\u00a0AK, Handsaker\u00a0RE et al (2014) Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N\u00a0Engl J Med 371(26):2477\u20132487","journal-title":"N Engl J Med"},{"issue":"26","key":"1388_CR5","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal\u00a0S, Fontanillas\u00a0P, Flannick\u00a0J et al (2014) Age-related clonal hematopoiesis associated with adverse outcomes. N\u00a0Engl J Med 371(26):2488\u20132498","journal-title":"N Engl J Med"},{"issue":"6","key":"1388_CR6","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","volume":"130","author":"F Zink","year":"2017","unstructured":"Zink\u00a0F, Stacey\u00a0SN, Norddahl\u00a0GL et\u00a0al (2017) Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. Blood 130(6):742\u2013752","journal-title":"Blood"},{"issue":"8","key":"1388_CR7","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.celrep.2015.02.005","volume":"10","author":"T McKerrell","year":"2015","unstructured":"McKerrell\u00a0T, Park\u00a0N, Moreno\u00a0T et al (2015) Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Rep 10(8):1239\u20131245","journal-title":"Cell Rep"},{"issue":"8","key":"1388_CR8","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1182\/bloodadvances.2020004062","volume":"5","author":"IA van Zeventer","year":"2021","unstructured":"van Zeventer\u00a0IA, Salzbrunn\u00a0JB, de Graaf\u00a0AO et\u00a0al (2021) Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged \u226580\u00a0years. Blood Adv 5(8):2115\u20132122","journal-title":"Blood Adv"},{"issue":"1","key":"1388_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ajhg.2017.05.013","volume":"101","author":"R Acuna-Hidalgo","year":"2017","unstructured":"Acuna-Hidalgo\u00a0R, Sengul\u00a0H, Steehouwer\u00a0M et al (2017) Ultra-sensitive sequencing identifies high prevalence of clonal hematopoiesis-associated mutations throughout adult life. Am J Hum Genet 101(1):50\u201364","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"1388_CR10","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1182\/blood-2017-04-777029","volume":"130","author":"M Buscarlet","year":"2017","unstructured":"Buscarlet\u00a0M, Provost\u00a0S, Zada\u00a0YF et\u00a0al (2017) DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions. Blood 130(6):753\u2013762","journal-title":"Blood"},{"issue":"16","key":"1388_CR11","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1182\/bloodadvances.2018024729","volume":"3","author":"EK Cook","year":"2019","unstructured":"Cook\u00a0EK, Izukawa\u00a0T, Young\u00a0S et\u00a0al (2019) Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis. Blood Adv 3(16):2482\u20132486","journal-title":"Blood Adv"},{"issue":"10","key":"1388_CR12","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi\u00a0C, Garagnani\u00a0P, Parini\u00a0P, Giuliani\u00a0C, Santoro\u00a0A (2018) Inflammaging: a\u00a0new immune\u2013metabolic viewpoint for age-related diseases. Nat Rev Endocrinol 14(10):576\u2013590","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"1388_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci\u00a0L, Fabbri\u00a0E (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 15(9):505\u2013522","journal-title":"Nat Rev Cardiol"},{"issue":"31","key":"1388_CR14","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1093\/eurheartj\/ehz961","volume":"41","author":"L Liberale","year":"2020","unstructured":"Liberale\u00a0L, Montecucco\u00a0F, Tardif\u00a0J\u2011C, Libby\u00a0P, Camici\u00a0GG (2020) Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease. Eur Heart\u00a0J 41(31):2974\u20132982","journal-title":"Eur Heart J"},{"issue":"3","key":"1388_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/gerona\/glr249","volume":"67A","author":"CAV Fragoso","year":"2012","unstructured":"Fragoso\u00a0CAV, Lee\u00a0PJ (2012) The aging lung. J\u00a0Gerontol A Biol Sci Med Sci 67A(3):233\u2013235","journal-title":"J. Gerontol. A. Biol. Sci. Med. Sci."},{"key":"1388_CR16","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.3389\/fimmu.2018.02795","volume":"9","author":"EC Stahl","year":"2018","unstructured":"Stahl\u00a0EC, Haschak\u00a0MJ, Popovic\u00a0B, Brown\u00a0BN (2018) Macrophages in the aging liver and age-related liver disease. Front Immunol 9:2795","journal-title":"Front Immunol"},{"issue":"7","key":"1388_CR17","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.3390\/cells9071614","volume":"9","author":"\u00c1 M\u00e9sz\u00e1ros","year":"2020","unstructured":"M\u00e9sz\u00e1ros \u00c1, Moln\u00e1r\u00a0K, N\u00f3gr\u00e1di\u00a0B et\u00a0al (2020) Neurovascular inflammaging in health and disease. Cells 9(7):1614","journal-title":"Cells"},{"issue":"3","key":"1388_CR18","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3390\/ijms20030614","volume":"20","author":"E Rezu\u0219","year":"2019","unstructured":"Rezu\u0219\u00a0E, Cardoneanu\u00a0A, Burlui\u00a0A et\u00a0al (2019) The link between inflammaging and degenerative joint diseases. int J Mol Sci 20(3):614","journal-title":"int J Mol Sci"},{"issue":"18","key":"1388_CR19","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1182\/blood.2020010163","volume":"138","author":"JS Hecker","year":"2021","unstructured":"Hecker\u00a0JS, Hartmann\u00a0L, Rivi\u00e8re\u00a0J et\u00a0al (2021) CHIP and hips: clonal hematopoiesis is common in patients undergoing hip arthroplasty and is associated with autoimmune disease. Blood 138(18):1727\u20131732","journal-title":"Blood"},{"issue":"8","key":"1388_CR20","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1182\/blood.2021014418","volume":"139","author":"LD Weeks","year":"2022","unstructured":"Weeks\u00a0LD, Marinac\u00a0CR, Redd\u00a0RA et al (2022) Age-related diseases of inflammation in myelodysplastic syndrome and chronic myelomonocytic leukemia. Blood 139(8):1246\u20131250. https:\/\/doi.org\/10.1182\/blood.2021014418","journal-title":"Blood"},{"issue":"6","key":"1388_CR21","doi-asserted-by":"publisher","first-page":"e264","DOI":"10.3324\/haematol.2019.223305","volume":"105","author":"CM Arends","year":"2020","unstructured":"Arends\u00a0CM, Weiss\u00a0M, Christen\u00a0F et al (2020) Clonal hematopoiesis in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. Haematologica 105(6):e264\u2013e267","journal-title":"Haematologica"},{"issue":"6","key":"1388_CR22","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s41591-021-01357-y","volume":"27","author":"NJ Dharan","year":"2021","unstructured":"Dharan\u00a0NJ, Yeh\u00a0P, Bloch\u00a0M et al (2021) HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults. Nat Med 27(6):1006\u20131011","journal-title":"Nat Med"},{"key":"1388_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.exphem.2019.11.008","volume":"80","author":"CRC Zhang","year":"2019","unstructured":"Zhang\u00a0CRC, Nix\u00a0D, Gregory\u00a0M et\u00a0al (2019) Inflammatory cytokines promote clonal hematopoiesis with specific mutations in ulcerative colitis patients. Exp Hematol 80:36\u201341.e3","journal-title":"Exp. Hematol."},{"issue":"4","key":"1388_CR24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1182\/blood.2019001793","volume":"135","author":"JW Hansen","year":"2020","unstructured":"Hansen\u00a0JW, Pedersen\u00a0DA, Larsen\u00a0LA et\u00a0al (2020) Clonal hematopoiesis in elderly twins: concordance, discordance, and mortality. Blood 135(4):261\u2013268","journal-title":"Blood"},{"issue":"4","key":"1388_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1182\/blood.2019001807","volume":"135","author":"MA Fabre","year":"2020","unstructured":"Fabre\u00a0MA, McKerrell\u00a0T, Zwiebel\u00a0M et\u00a0al (2020) Concordance for clonal hematopoiesis is limited in elderly twins. Blood 135(4):269\u2013273","journal-title":"Blood"},{"issue":"1","key":"1388_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","volume":"126","author":"DP Steensma","year":"2015","unstructured":"Steensma\u00a0DP, Bejar\u00a0R, Jaiswal\u00a0S et\u00a0al (2015) Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. Blood 126(1):9\u201316","journal-title":"Blood"},{"issue":"9","key":"1388_CR27","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1038\/s41375-018-0047-7","volume":"32","author":"CM Arends","year":"2018","unstructured":"Arends\u00a0CM, Galan-Sousa\u00a0J, Hoyer\u00a0K et al (2018) Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis. Leukemia 32(9):1908\u20131919","journal-title":"Leukemia"},{"issue":"6327","key":"1388_CR28","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1126\/science.aag1381","volume":"355","author":"JJ Fuster","year":"2017","unstructured":"Fuster\u00a0JJ, MacLauchlan\u00a0S, Zuriaga\u00a0MA et\u00a0al (2017) Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 355(6327):842\u2013847","journal-title":"Science"},{"issue":"2","key":"1388_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1701719","volume":"377","author":"S Jaiswal","year":"2017","unstructured":"Jaiswal\u00a0S, Natarajan\u00a0P, Silver\u00a0AJ et\u00a0al (2017) Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N\u00a0Engl J Med 377(2):111\u2013121","journal-title":"N Engl J Med"},{"issue":"12","key":"1388_CR30","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker\u00a0PM, Everett\u00a0BM, Thuren\u00a0T et\u00a0al (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N\u00a0Engl J Med 377(12):1119\u20131131","journal-title":"N Engl J Med"},{"issue":"12","key":"1388_CR31","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/nm.3733","volume":"20","author":"M Xie","year":"2014","unstructured":"Xie\u00a0M, Lu\u00a0C, Wang\u00a0J et al (2014) Age-related cancer mutations associated with clonal hematopoietic expansion. Nat Med 20(12):1472\u20131478","journal-title":"Nat Med"},{"issue":"1","key":"1388_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1001\/jamacardio.2018.3965","volume":"4","author":"L Dorsheimer","year":"2019","unstructured":"Dorsheimer\u00a0L, Assmus\u00a0B, Rasper\u00a0T et\u00a0al (2019) Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure. JAMA Cardiol 4(1):32\u201340","journal-title":"JAMA Cardiol"},{"issue":"4","key":"1388_CR33","doi-asserted-by":"publisher","first-page":"e003003","DOI":"10.1161\/CIRCGEN.120.003003","volume":"13","author":"S Cremer","year":"2020","unstructured":"Cremer\u00a0S, Kirschbaum\u00a0K, Berkowitsch\u00a0A et\u00a0al (2020) Multiple somatic mutations for clonal hematopoiesis are associated with increased mortality in patients with chronic heart failure. Circ Genom Precis Med 13(4):e3003","journal-title":"Circ Genom Precis Med"},{"issue":"3","key":"1388_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/eurheartj\/ehaa845","volume":"42","author":"B Assmus","year":"2020","unstructured":"Assmus\u00a0B, Cremer\u00a0S, Kirschbaum\u00a0K et al (2020) Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations. Eur Heart\u00a0J 42(3):257\u2013265","journal-title":"Eur Heart J"},{"issue":"8","key":"1388_CR35","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jacc.2017.12.037","volume":"71","author":"S Sano","year":"2018","unstructured":"Sano\u00a0S, Oshima\u00a0K, Wang\u00a0Y et al (2018) Tet2-mediated clonal hematopoiesis accelerates heart failure through a\u00a0mechanism involving the IL-1\u03b2\/NLRP3 inflammasome. J Am Coll Cardiol 71(8):875\u2013886","journal-title":"J. Am. Coll. Cardiol."},{"key":"1388_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.smim.2018.10.008","volume":"40","author":"C Franceschi","year":"2018","unstructured":"Franceschi\u00a0C, Zaikin\u00a0A, Gordleeva\u00a0S et\u00a0al (2018) Inflammaging 2018: an update and a\u00a0model. Semin Immunol 40:1\u20135","journal-title":"Semin Immunol"},{"key":"1388_CR37","doi-asserted-by":"publisher","first-page":"106787","DOI":"10.1016\/j.leukres.2022.106787","volume":"113","author":"Y Kusne","year":"2022","unstructured":"Kusne\u00a0Y, Xie\u00a0Z, Patnaik\u00a0MM (2022) Clonal hematopoiesis: molecular and clinical implications. Leuk Res 113:106787","journal-title":"Leuk. Res."},{"issue":"15","key":"1388_CR38","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1182\/blood-2012-08-448068","volume":"121","author":"LM Morton","year":"2013","unstructured":"Morton\u00a0LM, Dores\u00a0GM, Tucker\u00a0MA et al (2013) Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975\u20132008. Blood 121(15):2996\u20133004","journal-title":"Blood"},{"issue":"11","key":"1388_CR39","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","volume":"52","author":"KL Bolton","year":"2020","unstructured":"Bolton\u00a0KL, Ptashkin\u00a0RN, Gao\u00a0T et\u00a0al (2020) Cancer therapy shapes the fitness landscape of clonal hematopoiesis. nat Genet 52(11):1219\u20131226","journal-title":"nat Genet"},{"issue":"7540","key":"1388_CR40","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nature13968","volume":"518","author":"TN Wong","year":"2015","unstructured":"Wong\u00a0TN, Ramsingh\u00a0G, Young\u00a0AL et al (2015) The role of TP53 mutations in the origin and evolution of therapy-related AML. Nature 518(7540):552\u2013555","journal-title":"Nature"},{"issue":"5","key":"1388_CR41","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.stem.2018.10.004","volume":"23","author":"JI Hsu","year":"2018","unstructured":"Hsu\u00a0JI, Dayaram\u00a0T, Tovy\u00a0A et\u00a0al (2018) PPM1D mutations drive clonal hematopoiesis in response to cytotoxic chemotherapy. Cell Stem Cell 23(5):700\u2013713.e6","journal-title":"Cell Stem Cell"},{"issue":"1","key":"1388_CR42","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41467-018-02858-0","volume":"9","author":"TN Wong","year":"2018","unstructured":"Wong\u00a0TN, Miller\u00a0CA, Jotte\u00a0MRM et\u00a0al (2018) Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential. Nat Commun 9(1):455","journal-title":"Nat Commun"},{"issue":"4","key":"1388_CR43","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1200\/PO.20.00186","volume":"4","author":"PG Miller","year":"2020","unstructured":"Miller\u00a0PG, Gibson\u00a0CJ, Mehta\u00a0A et\u00a0al (2020) Fitness landscape of clonal hematopoiesis under selective pressure of immune checkpoint blockade. JCO Precis Oncol 4(4):1027\u20131033","journal-title":"JCO Precis Oncol"},{"issue":"7","key":"1388_CR44","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1016\/j.celrep.2019.04.064","volume":"27","author":"CA Ortmann","year":"2019","unstructured":"Ortmann\u00a0CA, Dorsheimer\u00a0L, Abou-El-Ardat\u00a0K et al (2019) Functional dominance of CHIP-mutated hematopoietic stem cells in patients undergoing autologous transplantation. Cell Rep 27(7):2022\u20132028.e3","journal-title":"Cell Rep"},{"issue":"7714","key":"1388_CR45","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41586-018-0317-6","volume":"559","author":"S Abelson","year":"2018","unstructured":"Abelson\u00a0S, Collord\u00a0G, Ng\u00a0SWK et\u00a0al (2018) Prediction of acute myeloid leukaemia risk in healthy individuals. Nature 559(7714):400\u2013404","journal-title":"Nature"},{"issue":"3","key":"1388_CR46","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1177\/0884533617700353","volume":"32","author":"MA Ricker","year":"2017","unstructured":"Ricker\u00a0MA, Haas\u00a0WC (2017) Anti-inflammatory diet in clinical practice: a review. Nutr Clin Pract 32(3):318\u2013325","journal-title":"Nutr Clin Pract"},{"key":"1388_CR47","doi-asserted-by":"publisher","DOI":"10.1161\/circ.142.suppl_3.16686","author":"R Bhattacharya","year":"2020","unstructured":"Bhattacharya\u00a0R, Zekavat\u00a0SM, Pirruccello\u00a0J et\u00a0al (2020) Abstract 16686: improved diet quality is associated with lower prevalence of clonal hematopoiesis of indeterminate potential. Circulation. https:\/\/doi.org\/10.1161\/circ.142.suppl_3.16686","journal-title":"Circulation"},{"issue":"6","key":"1388_CR48","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","volume":"170","author":"L Cimmino","year":"2017","unstructured":"Cimmino\u00a0L, Dolgalev\u00a0I, Wang\u00a0Y et al (2017) Restoration of TET2 function blocks aberrant self-renewal and leukemia progression. Cell 170(6):1079\u20131095.e20","journal-title":"Cell"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01388-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-022-01388-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01388-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T10:06:06Z","timestamp":1664186766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-022-01388-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1388"],"URL":"https:\/\/doi.org\/10.1007\/s00108-022-01388-8","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"assertion":[{"value":"7 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>A.\u00a0Burchert<\/b>: A.\u00a0Finanzielle Interessen: AOP Health: Vortragshonorare und Reisekostenunterst\u00fctzung im Rahmen des International Hematology Expert Meeting (IHEM); Pfizer: wissenschaftlicher Beirat, Vorsitz; Incyte: wissenschaftlicher Beirat.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: W3-Professur zellul\u00e4re Therapie, H\u00e4matologie und Onkologie, Universit\u00e4tsklinikum Gie\u00dfen und Marburg, Campus Marburg | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr H\u00e4matologie und Medizinische Onkologie (DGHO), American Society of Hematology (ASH), European Hematology Association (EHA).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}